Innovative Cancer Therapies Phoenix Molecular Designs specializes in developing targeted kinase inhibitors for breast cancer, presenting opportunities to establish partnerships with biotech firms and healthcare providers seeking advanced oncology treatments.
Recent Industry Recognition Winning the 2024 GRASP Advocate Choice Award enhances the company's credibility and visibility, making it attractive for investors and collaborators interested in promising biotech innovations.
Strategic Clinical Focus The company's focus on breast cancer, especially in resistant and metastatic forms, aligns with growing market demand for effective targeted therapies, suggesting a strong potential client base among oncologists and hospitals.
Funding & Growth Potential With $4.7 million in funding and a revenue range of up to $10 million, PhoenixMD is positioned for expansion, offering sales opportunities in research collaborations and early-stage clinical partnerships.
Engagement in Industry Events Active participation in major conferences like AACR and SABCS indicates openness to partnership and licensing opportunities, ideal for building relationships with strategic partners and government agencies.
$10B
$1B$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10BPhoenix Molecular Designs uses 8 technology products and services including RSS, Choices, jQuery, and more. Explore Phoenix Molecular Designs's tech stack below.
| Phoenix Molecular Designs Email Formats | Percentage |
| FLast@phoenixmd.ca | 95% |
| First.Last@phoenixmd.ca | 5% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Phoenix Molecular Designs is a clinical-stage biotechnology company that is developing small-molecule kinase inhibitors as a targeted therapy for cancer. We are focused on treating Breast Cancer. Our patented cancer compounds position us in the lead to fast-track our product to market as it fills an unmet medical need. Our cancer therapy has the potential to save lives and improve quality of life.
Company Overview
Media & News
Funding & FinancialsPhoenix Molecular Designs has raised a total of $4.7M of funding over 3 rounds. Their latest funding round was raised on Dec 20, 2020 in the amount of $4.7M.
Phoenix Molecular Designs's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsPhoenix Molecular Designs has raised a total of $4.7M of funding over 3 rounds. Their latest funding round was raised on Dec 20, 2020 in the amount of $4.7M.
Phoenix Molecular Designs's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com